OxyDial Inc

SEC filing

Other Health Care · Philadelphia, PA

Form D on EDGAR

Amount raised$700Ksold at filing

Total offering$1.5M$800K still open

Investors in the raise8count reported to the SEC

FiledMay 20, 2026first sale Mar 17, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Oleksandr ShestakovExecutive Officer, Director, Promoter

Alexey AprelevExecutive Officer, Director

David AlbertDirector

John YapaolaDirector

Executive officers, directors and promoters as listed on the Form D.